Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1237119

TREPROSTINIL
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)O)c3C[C@H]2C[C@H]1O

Basic Information

ChEMBL ID CHEMBL1237119
Name TREPROSTINIL
Phase Approved
Structure Type MOL
InChI Key PAJMKGZZBBTTOY-ZFORQUDYSA-N
Therapeutic ✓ Yes

Known Names

15-AU-81 15AU81 L-606 L606 LRX -15 LRX-15 Remodulin Rumodolin Treprostinil Treprostinilo Tresprostinil Tyvaso +3 more
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
20
Publications
15
Known Names
19
Indications
1
Mechanisms

Molecular Properties

390.5
MW (Da)
3.58
ALogP
4
HBA
3
HBD
87.0
PSA (Ų)
0.53
QED
0
Ro5 Violations
10
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2002
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral Parenteral Topical

Flags

Natural Product
USAN Stem -prost-
USAN Year 2002

Extended Properties

Molecular Formula C23H34O5
MW 390.52
Aromatic Rings 1
Heavy Atoms 28
NP-Likeness 1.34

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Prostanoid IP receptor agonist AGONIST Prostacyclin receptor

Indications

Hypertension, Pulmonary Hypertension, Pulmonary Pulmonary Arterial Hypertension Thrombosis Familial Primary Pulmonary Hypertension Idiopathic Pulmonary Fibrosis Lung Diseases, Interstitial Pulmonary Fibrosis Hernias, Diaphragmatic, Congenital Ischemia Peripheral Vascular Diseases Persistent Fetal Circulation Syndrome Pulmonary Disease, Chronic Obstructive Respiratory Distress Syndrome Diabetes Mellitus, Type 1 Diabetic Foot Reperfusion Injury Scleroderma, Systemic Raynaud Disease

ATC Classification

B01AC21
treprostinil
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTITHROMBOTIC AGENTS

Activity Summary

EC50 4 meas. best 9.22

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Prostaglandin D2 receptor
CHEMBL4427
EC50 9.22 9.22 0.6 1
Prostacyclin receptor
CHEMBL1995
EC50 8.72 8.72 1.9 1
Prostaglandin E2 receptor EP2 subtype
CHEMBL1881
EC50 8.21 8.21 6.2 1
Prostaglandin E2 receptor EP1 subtype
CHEMBL1811
EC50 6.54 6.54 285.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
37468498 10.1038/s41467-023-40064-9 Nuclear receptor subfamily 1 group I member 2 3
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Cannabinoid receptor 1 2
37468498 10.1038/s41467-023-40064-9 Progesterone receptor 2
37468498 10.1038/s41467-023-40064-9 Peroxisome proliferator-activated receptor gamma 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2B 2
37468498 10.1038/s41467-023-40064-9 Androgen receptor 2
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 1A 2
19603833 10.1021/jm9004658 Homo sapiens 1
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 1
37468498 10.1038/s41467-023-40064-9 Beta-1 adrenergic receptor 1
37468498 10.1038/s41467-023-40064-9 Glutamate receptor ionotropic, NMDA 1 1
37468498 10.1038/s41467-023-40064-9 Beta-2 adrenergic receptor 1

Data from ChEMBL 36 via Core Engine